During the past decade, CHI Franciscan Health System conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHI Franciscan Health System" #1 collaborator was "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "CHI Franciscan Health System" are "Atrial Fibrillation" (2 trials), "Stroke" (2 trials), "Bleeding" (1 trials), "Influenza" (1 trials) and "Leukemia" (1 trials). Many other conditions were trialed in "CHI Franciscan Health System" in a lesser frequency.

Most popular intervention types in "CHI Franciscan Health System" are "Drug" (5 trials), "Device" (4 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "EMBLEM S-ICD System" (1 trials), "Market-approved OAC" (1 trials), "Non-Vitamin K Oral Anticoagulant" (1 trials), "Oseltamivir" (1 trials) and "Peramivir 200 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHI Franciscan Health System" are 6 trials for "All" genders.

Currently, there are NaN active trials in "CHI Franciscan Health System". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in CHI Franciscan Health System, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHI Franciscan Health System, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".